Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 1.048
+0.034 (3.35%)
Oct 13, 2026, 5:22 PM CET
Diamyd Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Cash & Equivalents | 305.43 | 277.19 | 112.76 | 127.53 | 119.76 |
Short-Term Investments | - | - | 19.61 | - | 39.91 |
Cash & Short-Term Investments | 305.43 | 277.19 | 132.37 | 127.53 | 159.67 |
Cash Growth | 10.19% | 109.41% | 3.79% | -20.13% | 14.56% |
Accounts Receivable | 0.06 | - | 0.02 | 0.06 | 0.25 |
Other Receivables | 2.65 | 4.64 | 3.99 | 4.61 | 2.23 |
Receivables | 2.71 | 4.64 | 4.02 | 4.67 | 2.48 |
Prepaid Expenses | 1.18 | 10.58 | 22.76 | 8.61 | 10.86 |
Other Current Assets | - | - | - | - | 0 |
Total Current Assets | 309.31 | 292.4 | 159.14 | 140.81 | 173.01 |
Property, Plant & Equipment | 46.65 | 52.7 | 49.36 | 52.32 | 45.75 |
Long-Term Investments | 9.16 | 7.25 | 7.9 | 10.57 | 15.46 |
Long-Term Deferred Tax Assets | 0.13 | 0.19 | 0.3 | 1.54 | 1.68 |
Other Long-Term Assets | 0 | 0.09 | 0.34 | 0.57 | 0.63 |
Total Assets | 365.25 | 352.64 | 217.04 | 205.81 | 236.52 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Accounts Payable | 20.91 | 11.96 | 16.61 | 4.89 | 9.78 |
Accrued Expenses | - | 7.61 | 14.5 | 5.54 | 4.97 |
Current Unearned Revenue | 6.86 | - | - | - | 0.06 |
Other Current Liabilities | 6.29 | 7.92 | 8.92 | 9.43 | 6.56 |
Total Current Liabilities | 34.07 | 27.48 | 40.03 | 19.85 | 21.37 |
Pension & Post-Retirement Benefits | - | 0.11 | 0.42 | 0.69 | 0.78 |
Other Long-Term Liabilities | 87.6 | 45.04 | 30.67 | 15.87 | 0 |
Total Liabilities | 121.67 | 72.64 | 71.12 | 36.41 | 22.15 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Common Stock | 15.72 | 13.95 | 10.11 | 8.7 | 7.8 |
Additional Paid-In Capital | 1,100 | 884.67 | 586.55 | 460.29 | 390.51 |
Retained Earnings | - | - | - | -299.59 | -183.93 |
Comprehensive Income & Other | -871.71 | -618.61 | -450.74 | - | - |
Shareholders' Equity | 243.59 | 280 | 145.92 | 169.4 | 214.38 |
Total Liabilities & Equity | 365.25 | 352.64 | 217.04 | 205.81 | 236.52 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Net Cash (Debt) | 305.43 | 277.19 | 132.37 | 127.53 | 159.67 |
Net Cash Growth | 10.19% | 109.41% | 3.79% | -20.13% | 14.56% |
Net Cash Per Share | 2.10 | 2.46 | 1.40 | 1.63 | 2.09 |
Filing Date Shares Outstanding | 154.98 | 137.5 | 104.09 | 85.78 | 76.93 |
Total Common Shares Outstanding | 154.98 | 137.5 | 99.72 | 85.78 | 76.93 |
Working Capital | 275.24 | 264.92 | 119.12 | 120.96 | 151.64 |
Book Value Per Share | 1.57 | 2.04 | 1.46 | 1.97 | 2.79 |
Tangible Book Value | 243.59 | 280 | 145.92 | 169.4 | 214.38 |
Tangible Book Value Per Share | 1.57 | 2.04 | 1.46 | 1.97 | 2.79 |
Land | - | - | - | - | 24.48 |
Buildings | - | 41.47 | 39.84 | 32.2 | - |
Machinery | - | 37.21 | 29.67 | 28.87 | 27.38 |
Construction In Progress | - | 0.99 | 0.41 | 0.83 | - |